Thu, September 15, 2022
Wed, September 14, 2022
Tue, September 13, 2022

Derek Archila Maintained (CABA) at Buy with Decreased Target to $4 on, Sep 14th, 2022

Derek Archila of Wells Fargo, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $14 to $4 on, Sep 14th, 2022.

Derek has made no other calls on CABA in the last 4 months.



There are 3 other peers that have a rating on CABA. Out of the 3 peers that are also analyzing CABA, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $3 on, Tuesday, August 30th, 2022


These are the ratings of the 2 analyists that currently disagree with Derek


  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $13 on, Friday, August 12th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, May 25th, 2022